{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:21:04Z","timestamp":1790882464042,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"PNRR","award":["MAD-2022-12375755"],"award-info":[{"award-number":["MAD-2022-12375755"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-025-03931-z","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T06:10:50Z","timestamp":1747807850000},"page":"4251-4259","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of citrus essential oil petit grain in growth and motility reduction of hypopharyngeal squamous cell carcinoma (FaDu) in vitro model"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1705-2448","authenticated-orcid":false,"given":"Veronica","family":"Russo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3460-696X","authenticated-orcid":false,"given":"Maria Antonietta","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9863-4695","authenticated-orcid":false,"given":"Rossella","family":"Ricchiuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9327-6660","authenticated-orcid":false,"given":"Marika","family":"Alborghetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0708-8282","authenticated-orcid":false,"given":"Antonietta","family":"Arcella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"key":"3931_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"3931_CR2","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1097\/00005537-199708000-00001","volume":"107","author":"HT Hoffman","year":"1997","unstructured":"Hoffman HT, Karnell LH, Shah JP, Ariyan S, Brown GS, Fee WE, Glass AG, Goepfert H, Ossoff RH, Fremgen AM. Hypopharyngeal cancer patient care evaluation. Laryngoscope. 1997;107(8):1005\u201317. https:\/\/doi.org\/10.1097\/00005537-199708000-00001. (PMID: 9260999).","journal-title":"Laryngoscope"},{"key":"3931_CR3","doi-asserted-by":"publisher","first-page":"6353","DOI":"10.2147\/CMAR.S203439","volume":"11","author":"J Zeng","year":"2019","unstructured":"Zeng J, Tang Y, Wu P, Fang X, Wang W, Fan Y, Li X, Zhao S. Alcohol consumption, tobacco smoking, betel quid chewing and oral health associations with hypopharyngeal cancer among men in Central South China: a case-control study. Cancer Manag Res. 2019;11:6353\u201364.","journal-title":"Cancer Manag Res"},{"issue":"11","key":"3931_CR4","first-page":"3282","volume":"48","author":"WJ Blot","year":"1988","unstructured":"Blot WJ, McLaughlin JK, Winn DM, Austin DF, Greenberg RS, Preston-Martin S, Bernstein L, Schoenberg JB, Stemhagen A, Fraumeni JF. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 1988;48(11):3282\u20137.","journal-title":"Cancer Res"},{"issue":"2","key":"3931_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/jnci\/86.2.131","volume":"86","author":"GL Day","year":"1994","unstructured":"Day GL, Blot WJ, Shore RE, McLaughlin JK, Austin DF, Greenberg RS, Liff JM, Preston-Martin S, Sarkar S, Schoenberg JB. Second cancers following oral and pharyngeal cancers: role of tobacco and alcohol. J Natl Cancer Inst. 1994;86(2):131\u20137.","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"3931_CR6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/aje\/kwj208","volume":"164","author":"O Shangina","year":"2006","unstructured":"Shangina O, Brennan P, Szeszenia-Dabrowska N, Mates D, Fabi\u00e1nov\u00e1 E, Fletcher T, A, t\u2019Mannetje P, Boffetta D, Zaridze. Occupational exposure and laryngeal and hypopharyngeal cancer risk in central and eastern Europe. Am J Epidemiol. 2006;164(4):367\u201375.","journal-title":"Am J Epidemiol"},{"issue":"9","key":"3931_CR7","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.3390\/jcm12093264.PMID:37176704;PMCID:PMC10179259","volume":"12","author":"L Nokovitch","year":"2023","unstructured":"Nokovitch L, Maquet C, Crampon F, Taihi I, Roussel LM, Obongo R, Virard F, Fervers B, Deneuve S. Oral cavity squamous cell carcinoma risk factors: State of the art. J Clin Med. 2023;12(9):3264. https:\/\/doi.org\/10.3390\/jcm12093264.PMID:37176704;PMCID:PMC10179259.","journal-title":"J Clin Med"},{"issue":"19","key":"3931_CR8","doi-asserted-by":"publisher","first-page":"4912","DOI":"10.3390\/cancers13194912.PMID:34638398;PMCID:PMC8508236","volume":"13","author":"G Anderson","year":"2021","unstructured":"Anderson G, Ebadi M, Vo K, Novak J, Govindarajan A, Amini A. An updated review on head and neck cancer treatment with radiation therapy. Cancers (Basel). 2021;13(19):4912. https:\/\/doi.org\/10.3390\/cancers13194912.PMID:34638398;PMCID:PMC8508236.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"3931_CR9","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1097\/00005537-200205000-00011","volume":"112","author":"C Godballe","year":"2002","unstructured":"Godballe C, J\u00f8rgensen K, Hansen O, Bastholt L. Hypopharyngeal cancer: results of treatment based on radiation therapy and salvage surgery. Laryngoscope. 2002;112(5):834\u20138. https:\/\/doi.org\/10.1097\/00005537-200205000-00011. (PMID: 12150614).","journal-title":"Laryngoscope"},{"key":"3931_CR10","first-page":"47","volume":"83","author":"HE Eckel","year":"2019","unstructured":"Eckel HE, Bradley PJ. Treatment options for hypopharyngeal cancer. Adv Otorhinolaryngol. 2019;83:47\u201353.","journal-title":"Adv Otorhinolaryngol"},{"issue":"3","key":"3931_CR11","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.3390\/jcm12031131.PMID:36769779;PMCID:PMC9918009","volume":"12","author":"P Mattei","year":"2023","unstructured":"Mattei P, Gal J, Chamorey E, Dassonville O, Poissonnet G, Aloi D, Barret M, Safta I, Saada E, Sudaka A, Culi\u00e9 D, Bozec A. Docetaxel-cisplatin-fluorouracil induction chemotherapy for larynx preservation in patients with locally advanced hypopharyngeal cancer: Predictive factors of oncologic and functional outcomes. J Clin Med. 2023;12(3):1131. https:\/\/doi.org\/10.3390\/jcm12031131.PMID:36769779;PMCID:PMC9918009.","journal-title":"J Clin Med"},{"key":"3931_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.640392.PMID:34026617;PMCID:PMC8138159","volume":"11","author":"Y Kanno","year":"2021","unstructured":"Kanno Y, Chen CY, Lee HL, Chiou JF, Chen YJ. Molecular mechanisms of chemotherapy resistance in head and neck cancers. Front Oncol. 2021;11: 640392. https:\/\/doi.org\/10.3389\/fonc.2021.640392.PMID:34026617;PMCID:PMC8138159.","journal-title":"Front Oncol"},{"issue":"5","key":"3931_CR13","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1080\/1120009X.2021.1873633","volume":"33","author":"A Arcella","year":"2021","unstructured":"Arcella A, Sanchez M. Natural substances to potentiate canonical glioblastoma chemotherapy. J Chemother. 2021;33(5):276\u201387.","journal-title":"J Chemother"},{"issue":"6","key":"3931_CR14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.40768.PMID:37485104;PMCID:PMC10362094","volume":"15","author":"MA Shah","year":"2023","unstructured":"Shah MA, Sankeshwari RM, Ankola AV, Dodamani S, Tendulkar S, Jalihal S, Pai Khot AJ, Varghese AS, Chavan P. Antimicrobial efficacy of essential oils and their combination against microorganisms associated with postradiation therapy in patients with head and neck cancer: An in vitro study. Cureus. 2023;15(6): e40768. https:\/\/doi.org\/10.7759\/cureus.40768.PMID:37485104;PMCID:PMC10362094.","journal-title":"Cureus"},{"issue":"7","key":"3931_CR15","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.3390\/ijms19071966.PMID:29976894;PMCID:PMC6073409","volume":"19","author":"NS Dosoky","year":"2018","unstructured":"Dosoky NS, Setzer WN. Biological activities and safety of Citrus spp. Essential Oils Int J Mol Sci. 2018;19(7):1966. https:\/\/doi.org\/10.3390\/ijms19071966.PMID:29976894;PMCID:PMC6073409.","journal-title":"Essential Oils Int J Mol Sci"},{"issue":"4","key":"3931_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/medicines3040025.PMID:28930135;PMCID:PMC5456241","volume":"3","author":"W Dhifi","year":"2016","unstructured":"Dhifi W, Bellili S, Jazi S, Bahloul N, Mnif W. Essential Oils\u2019 Chemical Characterization and Investigation of Some Biological Activities: A Critical Review. Medicines (Basel). 2016;3(4):25. https:\/\/doi.org\/10.3390\/medicines3040025.PMID:28930135;PMCID:PMC5456241.","journal-title":"Medicines (Basel)"},{"issue":"7","key":"3931_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131321.PMID:26132146;PMCID:PMC4488432","volume":"10","author":"A Bag","year":"2015","unstructured":"Bag A, Chattopadhyay RR. Evaluation of synergistic antibacterial and antioxidant efficacy of essential oils of spices and herbs in combination. PLoS ONE. 2015;10(7): e0131321. https:\/\/doi.org\/10.1371\/journal.pone.0131321.PMID:26132146;PMCID:PMC4488432.","journal-title":"PLoS ONE"},{"issue":"19","key":"3931_CR18","doi-asserted-by":"publisher","first-page":"5832","DOI":"10.3390\/molecules26195832","volume":"26","author":"S Maksoud","year":"2021","unstructured":"Maksoud S, Abdel-Massih RM, Rajha HN, Louka N, Chemat F, Barba FJ, Debs E. Citrus aurantium L. active constituents, biological effects and extraction methods. An updated review. Molecules. 2021;26(19):5832.","journal-title":"Molecules"},{"issue":"3","key":"3931_CR19","doi-asserted-by":"publisher","first-page":"12713","DOI":"10.15835\/nbha50312713","volume":"50","author":"W Saengha","year":"2022","unstructured":"Saengha W, Karirat T, Buranrat B, Katisart T, Ma NL. Cytotoxicity and antiproliferative activity of essential oils from lemon, wild orange and petitgrain against MCF-7, HepG2 and HeLa cancer cells. Notulae Botanicae Horti Agrobotanici Cluj-Napoca. 2022;50(3):12713.","journal-title":"Notulae Botanicae Horti Agrobotanici Cluj-Napoca"},{"issue":"1","key":"3931_CR20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13045-021-01137-8.PMID:34419139;PMCID:PMC8379749","volume":"14","author":"H Hua","year":"2021","unstructured":"Hua H, Zhang H, Chen J, Wang J, Liu J, Jiang Y. Targeting Akt in cancer for precision therapy. J Hematol Oncol. 2021;14(1):128. https:\/\/doi.org\/10.1186\/s13045-021-01137-8.PMID:34419139;PMCID:PMC8379749.","journal-title":"J Hematol Oncol"},{"key":"3931_CR21","doi-asserted-by":"publisher","first-page":"1186712","DOI":"10.3389\/fphar.2023.1186712.PMID:37560476;PMCID:PMC10407561","volume":"14","author":"D Liang","year":"2023","unstructured":"Liang D, Liu L, Zhao Y, Luo Z, He Y, Li Y, Tang S, Tang J, Chen N. Targeting extracellular matrix through phytochemicals: a promising approach of multi-step actions on the treatment and prevention of cancer. Front Pharmacol. 2023;14:1186712. https:\/\/doi.org\/10.3389\/fphar.2023.1186712.PMID:37560476;PMCID:PMC10407561.","journal-title":"Front Pharmacol"},{"issue":"8","key":"3931_CR22","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.3390\/biomedicines11082128","volume":"11","author":"KN Rao","year":"2023","unstructured":"Rao KN, Pai PS, Dange P, Kowalski LP, Strojan P, M\u00e4kitie AA, Guntinas-Lichius O, Robbins KT, Rodrigo JP, Eisbruch A, Takes RP, de Bree R, Coca-Pelaz A, Piazza C, Chiesa-Estomba C, L\u00f3pez F, Saba NF, Rinaldo A, Ferlito A. Survival outcomes in T3 laryngeal cancers: Primary total laryngectomy vs. concurrent chemoradiation or radiation therapy-a meta-analysis. Biomedicines. 2023;11(8):2128.","journal-title":"Biomedicines"},{"issue":"10","key":"3931_CR23","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1093\/annonc\/mds065","volume":"23","author":"Lefebvre JL, Andry G, Chevalier D, Luboinski B, Collette L, Traissac L, de Raucourt D, Langendijk JA. EORTC Head and Neck Cancer Group","year":"2012","unstructured":"Lefebvre JL, Andry G, Chevalier D, Luboinski B, Collette L, Traissac L, de Raucourt D, Langendijk JA. EORTC Head and Neck Cancer Group. Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891. Ann Oncol. 2012;23(10):2708\u201314.","journal-title":"Ann Oncol"},{"key":"3931_CR24","doi-asserted-by":"publisher","first-page":"22194","DOI":"10.18632\/oncotarget.25175.PMID:29774132;PMCID:PMC5955138","volume":"31","author":"R Vengoji","year":"2018","unstructured":"Vengoji R, Macha MA, Batra SK, Shonka NA. Natural products: a hope for glioblastoma patients. Oncotarget. 2018;31:22194\u2013219. https:\/\/doi.org\/10.18632\/oncotarget.25175.PMID:29774132;PMCID:PMC5955138.","journal-title":"Oncotarget"},{"issue":"4","key":"3931_CR25","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.3171\/2014.12.JNS14512","volume":"123","author":"A Arcella","year":"2015","unstructured":"Arcella A, Oliva MA, Staffieri S, Aalberti S, Grillea G, Madonna M, Bartolo M, Pavone L, Giangaspero F, Cantore G, Frati A. In vitro and in vivo effect of human lactoferrin on glioblastoma growth. J Neurosurg. 2015;123(4):1026\u201335.","journal-title":"J Neurosurg"},{"issue":"39","key":"3931_CR26","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.18632\/oncotarget.26994.PMID:31231472;PMCID:PMC6570463","volume":"10","author":"MNA Kamarudin","year":"2019","unstructured":"Kamarudin MNA, Parhar I. Emerging therapeutic potential of anti-psychotic drugs in the management of human glioma: A comprehensive review. Oncotarget. 2019;10(39):3952\u201377. https:\/\/doi.org\/10.18632\/oncotarget.26994.PMID:31231472;PMCID:PMC6570463.","journal-title":"Oncotarget"},{"issue":"3","key":"3931_CR27","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1080\/17512433.2020.1738218","volume":"13","author":"ER Sauter","year":"2020","unstructured":"Sauter ER. Cancer prevention and treatment using combination therapy with natural compounds. Expert Rev Clin Pharmacol. 2020;13(3):265\u201385. https:\/\/doi.org\/10.1080\/17512433.2020.1738218. (Epub 2020 Apr 3 PMID: 32154753).","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"1","key":"3931_CR28","doi-asserted-by":"publisher","first-page":"5120","DOI":"10.1038\/s41467-020-18794-x.PMID:33037194;PMCID:PMC7547708","volume":"11","author":"J Winkler","year":"2020","unstructured":"Winkler J, Abisoye-Ogunniyan A, Metcalf KJ, Werb Z. Concepts of extracellular matrix remodelling in tumour progression and metastasis. Nat Commun. 2020;11(1):5120. https:\/\/doi.org\/10.1038\/s41467-020-18794-x.PMID:33037194;PMCID:PMC7547708.","journal-title":"Nat Commun"},{"issue":"6","key":"3931_CR29","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2016.48","volume":"12","author":"XM Meng","year":"2016","unstructured":"Meng XM, Nikolic-Paterson DJ, Lan HY. TGF-\u03b2: the master regulator of fibrosis. Nat Rev Nephrol. 2016;12(6):325\u201338.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"3931_CR30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13045-020-00904-3.PMID:32493414;PMCID:PMC7268628","volume":"13","author":"H Hua","year":"2020","unstructured":"Hua H, Kong Q, Yin J, Zhang J, Jiang Y. Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy. J Hematol Oncol. 2020;13(1):64. https:\/\/doi.org\/10.1186\/s13045-020-00904-3.PMID:32493414;PMCID:PMC7268628.","journal-title":"J Hematol Oncol"},{"key":"3931_CR31","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.3390\/cancers13102478.PMID:34069554;PMCID:PMC8160938","volume":"10","author":"GN Tzanakakis","year":"2021","unstructured":"Tzanakakis GN, Giatagana EM, Berdiaki A, Spyridaki I, Hida K, Neagu M, Tsatsakis AM, Nikitovic D. The role of IGF\/IGF-IR-signaling and extracellular matrix effectors in bone sarcoma pathogenesis. Cancers (Basel). 2021;10:2478. https:\/\/doi.org\/10.3390\/cancers13102478.PMID:34069554;PMCID:PMC8160938.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"3931_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40164-021-00212-7.PMID:33622411;PMCID:PMC7903722","volume":"10","author":"S Yang","year":"2021","unstructured":"Yang S, Zhang H, Yang H, Zhang J, Wang J, Luo T, Jiang Y, Hua H. SEPHS1 promotes SMAD2\/3\/4 expression and hepatocellular carcinoma cells invasion. Exp Hematol Oncol. 2021;10(1):17. https:\/\/doi.org\/10.1186\/s40164-021-00212-7.PMID:33622411;PMCID:PMC7903722.","journal-title":"Exp Hematol Oncol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-03931-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-025-03931-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-03931-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:03:29Z","timestamp":1761908609000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-025-03931-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":32,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["3931"],"URL":"https:\/\/doi.org\/10.1007\/s12094-025-03931-z","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]},"assertion":[{"value":"22 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"We did not use human material from patients. FADU cells are a commercial cell line . FaDu cancer cell line was employed from Sigma Aldrich Collection (LGC Promochem, Teddington, UK).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and informed consent"}},{"value":"All authors have approved the submission and publication of this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}